After record profits and strong growth in 2023, the industry’s momentum faced limitations in 2024 due to rising raw material costs and increased market competition.

Related Keywords

, Mirae Asset Vietnam Securities Company , Securities Corporation , Imexpharm Corporation , Active Pharmaceutical Ingredients , Pharmaceutical Law , Asset Vietnam Securities Company ,